Physician profile
Jerry Yee
NPI 1871661314
$21,305.25
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,513 · 2020: $6,387 · 2021: $9,273 · 2022: $1,134.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $4,406.08 | 2019 | |
| Akebia Therapeutics INC | $4,360.00 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $3,946.17 | 2021-2022 | |
| Glaxosmithkline, LLC. | $3,680.00 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $2,600.00 | 2020 | |
| Vifor Pharma, INC. | $2,206.50 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $106.50 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Yee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.